Abstract |
Therapy-responsive biomarkers are an important and unmet need in the muscular dystrophy field where new treatments are currently in clinical trials. By using a comprehensive high-resolution mass spectrometry approach and western blot validation, we found that two fragments of the myofibrillar structural protein myomesin-3 (MYOM3) are abnormally present in sera of Duchenne muscular dystrophy (DMD) patients, limb-girdle muscular dystrophy type 2D ( LGMD2D) and their respective animal models. Levels of MYOM3 fragments were assayed in therapeutic model systems: (1) restoration of dystrophin expression by antisense oligonucleotide-mediated exon-skipping in mdx mice and (2) stable restoration of α- sarcoglycan expression in KO-SGCA mice by systemic injection of a viral vector. Following administration of the therapeutic agents MYOM3 was restored toward wild-type levels. In the LGMD model, where different doses of vector were used, MYOM3 restoration was dose-dependent. MYOM3 fragments showed lower inter-individual variability compared with the commonly used creatine kinase assay, and correlated better with the restoration of the dystrophin-associated protein complex and muscle force. These data suggest that the MYOM3 fragments hold promise for minimally invasive assessment of experimental therapies for DMD and other neuromuscular disorders.
|
Authors | Jérémy Rouillon, Jérôme Poupiot, Aleksandar Zocevic, Fatima Amor, Thibaut Léger, Camille Garcia, Jean-Michel Camadro, Brenda Wong, Robin Pinilla, Jérémie Cosette, Anna M L Coenen-Stass, Graham Mcclorey, Thomas C Roberts, Matthew J A Wood, Laurent Servais, Bjarne Udd, Thomas Voit, Isabelle Richard, Fedor Svinartchouk |
Journal | Human molecular genetics
(Hum Mol Genet)
Vol. 24
Issue 17
Pg. 4916-32
(Sep 01 2015)
ISSN: 1460-2083 [Electronic] England |
PMID | 26060189
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2015. Published by Oxford University Press. |
Chemical References |
- Biomarkers
- Blood Proteins
- Connectin
- MYOM3 protein, human
- Creatine Kinase
|
Topics |
- Adolescent
- Adult
- Animals
- Biomarkers
- Blood Proteins
(metabolism)
- Case-Control Studies
- Child
- Child, Preschool
- Connectin
(blood, metabolism)
- Creatine Kinase
- Disease Models, Animal
- Humans
- Mass Spectrometry
- Mice
- Mice, Inbred mdx
- Muscular Dystrophies
(blood, metabolism, therapy)
- Muscular Dystrophy, Duchenne
(blood, metabolism)
- Proteomics
(methods)
- Treatment Outcome
- Young Adult
|